Iovance Biotherapeutics (IOVA)
(Delayed Data from NSDQ)
$8.33 USD
+0.37 (4.65%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $8.34 +0.01 (0.12%) 4:26 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -0.42 |
Last EPS Surprise | 6.67% |
ABR | 1.14 |
Earnings ESP
|
10.12% |
---|---|
Current Year | -1.35 |
Next Year | -0.86 |
EPS (TTM) | -1.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 26.01M | 54.21M | 159.38M | 407.31M |
# of Estimates | 6 | 6 | 7 | 6 |
High Estimate | 39.20M | 85.48M | 250.00M | 595.37M |
Low Estimate | 5.20M | 11.20M | 33.20M | 130.50M |
Year ago Sales | 0.24M | 0.47M | 1.19M | 159.38M |
Year over Year Growth Est. | 10,735.42% | 11,434.68% | 13,304.29% | 155.56% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.31 | -1.35 | -0.86 |
# of Estimates | 7 | 6 | 8 | 7 |
Most Recent Consensus | -0.44 | -0.45 | -1.33 | -0.56 |
High Estimate | -0.31 | -0.22 | -0.76 | -0.22 |
Low Estimate | -0.44 | -0.45 | -1.79 | -1.52 |
Year ago EPS | -0.47 | -0.46 | -1.89 | -1.35 |
Year over Year Growth Est. | 21.28% | 32.61% | 28.57% | 35.70% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.31 | -1.35 | -0.86 |
7 Days Ago | -0.36 | -0.31 | -1.34 | -0.84 |
30 Days Ago | -0.36 | -0.31 | -1.34 | -0.84 |
60 Days Ago | -0.37 | -0.31 | -1.36 | -0.94 |
90 Days Ago | -0.39 | -0.33 | -1.41 | -0.95 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.33 | -0.31 | -1.35 | -0.89 |
Zacks Consensus Estimate | -0.37 | -0.31 | -1.35 | -0.86 |
Earnings ESP | 10.12% | -1.09% | -0.28% | -2.98% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.42 | -0.45 | -0.46 | -0.47 | NA |
Estimate | -0.45 | -0.44 | -0.46 | -0.81 | NA |
Difference | 0.03 | -0.01 | 0.00 | 0.34 | 0.09 |
Surprise | 6.67% | -2.27% | 0.00% | 41.98% | 11.60% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more